Advanced search
Publication Cover
Clinical Toxicology Volume 56, 2018 - Issue 6
Submit an article Journal homepage
313
Views
1
CrossRef citations to date
0
Altmetric
Short Communication

Extracorporeal elimination of butalbital in acute aspirin–butalbital–caffeine–codeine (Fiorinal with Codeine) poisoning

Janelle O. PoyantDepartment of Pharmacy, Tufts Medical Center, Boston, MA, USA; ORCID Iconhttp://orcid.org/0000-0001-8911-8248
ORCID Icon,
Robert AlbrightDivision of Nephrology and Hypertension, Mayo Clinic, Rochester, MN, USA;
,
Jeremy ClainDivision of Pulmonary and Critical Care Medicine, Mayo Clinic, Rochester, MN, USA;
,
Govind PandompatamDivision of Pulmonary and Critical Care Medicine, Mayo Clinic, Rochester, MN, USA;
&
Erin F. BarretoDepartment of Pharmacy, Mayo Clinic, Rochester, MN, USACorrespondence[email protected]
Pages 439-441 | Received 11 Jun 2017, Accepted 26 Oct 2017, Published online: 10 Nov 2017

References

  • Fiorinal with Codeine(R). [package insert]. Watson Pharmaceuticals I, Corona, CA; 2007.
  • Nelson L, Lewis R, Goldfrank. Goldfrank's Toxicologic Emergencies. New York: McGraw-Hill Medical; 2011.
  • Juurlink DN, Gosselin S, Kielstein JT, et al. Extracorporeal treatment for salicylate poisoning: systematic review and recommendations from the EXTRIP workgroup. Ann Emerg Med. 2015;66:165–181.
  • Mactier R, Laliberté M, Mardini J, et al. Extracorporeal treatment for barbiturate poisoning: recommendations from the EXTRIP workgroup. Am J Kidney Dis. 2014;64:347–358.
  • Lavergne V, Ouellet G, Bouchard J, et al. Guidelines for reporting case studies on extracorporeal treatments in poisonings: methodology. Semin Dial. 2014;27:407–414.
  • Buckley NA, Whyte IM, Dawson AH, et al. Correlations between prescriptions and drugs taken in self-poisoning. Implications for prescribers and drug regulation. Med J Aust. 1995;162:194–197.
  • Hoyland K, Hoy M, Austin R, et al. Successful use of haemodialysis to treat phenobarbital overdose. BMJ Case Rep. 2013;2013:1–3.
  • Dawson AH, Whyte IM. Therapeutic drug monitoring in drug overdose. Br J Clin Pharmacol. 1999;48:278–283.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.